医学
免疫疗法
不利影响
食管癌
癌症免疫疗法
癌症
化疗
肿瘤科
内科学
临床疗效
重症监护医学
作者
Yingjie Ma,Junxian Yu,Xiaoting Ma,Li Qin,Qiang Su,Bangwei Cao
摘要
Esophageal cancer (EC) is the seventh most common cancer worldwide. Patients with EC have a generally poor prognosis mainly due to the lack of effective treatments. Cancer immunotherapy is a promising novel treatment option for EC. This literature review investigated the clinical efficacy of immunotherapy either alone or in combination with chemotherapy or targeted therapy. In addition, we analyzed the adverse events associated with immune checkpoint inhibitors (ICIs). In conclusion, ICIs increase the efficacy of EC treatments, thereby improving the outcomes of EC patients. The findings of this study may help enhance the response to immunotherapy, diminish toxicity, and thus eventually improve medical care for patients with EC.
科研通智能强力驱动
Strongly Powered by AbleSci AI